Measuring preferences for colorectal cancer screening: What are the implications for moving forward?

Patient

Volumn 3, Issue 2, 2010, Pages 79-89

  Marshall, Deborah ^a   McGregor, S Elizabeth ^a,b   Currie, Gillian ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colorectal cancer; Conjoint analysis; Patient preference; Prevention; Screening

Indexed keywords

CANCER PATIENT; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL CANCER SCREENING; DIAGNOSTIC VALUE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 77953373471     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11532250-000000000-00000     Document Type: Review

References (55)

1. Salkeld G, Solomon M, Short L, et al. Evidence-based consumer choice: a case study in colorectal cancer screening. Aust N Z J Public Health 2003; 27: 449-455 (Pubitemid 37038228)
2. Parker M. The ethics of evidence-based patient choice. Health Expect 2001; 4 (2): 87-91 (Pubitemid 32464019)
3. Dolan JG. Patient priorities in colorectal cancer screening decisions. Health Expect 2005; 8 (4): 334-344 (Pubitemid 41641183)
4. KrahnM,Naglie G. The next step in guideline development: incorporating patient preferences. JAMA 2008; 300 (4): 436-438 (Pubitemid 352040257)
5. Bensing J. Bridging the gap: the separate worlds of evidencebased medicine and patient-centered medicine. Patient Educ Couns 2000; 39 (1): 17-25
6. Bryan S, Dolan P, Bryan S, et al. Discrete choice experiments in health economics: for better or for worse? Eur J Health Econ 2004; 5 (3): 199-202 (Pubitemid 39382517)
7. Ryan M. A role for conjoint analysis in technology assessment in health care? Int J TechnolAssess Health Care 1999; 15 (3): 443-457 (Pubitemid 29466178)
8. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, 1968
9. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008 Nov 4; 149 (9): 627-637
10. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009; 104 (3): 739-750
11. Pignone M, Sox HC, Pignone M, et al. Screening guidelines for colorectal cancer: a twice-told tale. Ann Intern Med 2008; 149 (9): 680-682
12. Colorectal cancer screening: Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2001; 165: 206-208
13. DeBourcy AC, Lichtenberger S, Felton S, et al. Communitybased preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 2008; 23 (2): 169-174
14. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening. Can J Gastroenterol 2004; 18: 93-99 (Pubitemid 38418034)
15. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000; 95 (4): 868-877
16. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale. Update based on new evidence. Gastroenterology 2003; 124: 544-560 (Pubitemid 36169269)
17. Rhodes JM. Colorectal cancer screening in the UK: joint position statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland. Gut 2000; 46 (6): 746-748
18. Liang SY, Phillips KA, Nagamine M, et al. Rates and predictors of colorectal cancer screening. Prev Chronic Dis 2006; 3 (4): A117
19. Shapiro JA, Seeff LC, Thompson TD, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008; 17 (7): 1623-1630
20. Wilkins K, Shields M. Colorectal cancer testing in Canada: 2008. Health Rep 2009; 20 (3): 21-30
21. Marshall DA, Johnson FR, Phillips KA, et al. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 2007; 10: 415-430
22. Forbes C, Jepson R,Martin-Hirsch P. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 1999; (3): CD002834
23. Ling BS, Moskowitz MA, Wachs D, et al. Attitudes toward colorectal cancer screening tests. J Gen Intern Med 2001; 16: 822-830
24. Woolf SH. The best screening test for colorectal cancer: a personal choice. N Engl J Med 2000; 343 (22): 1641-1643
25. Dominitz JA, Provenzale D, Dominitz JA, et al. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol 1997; 92 (12): 2171-2178 (Pubitemid 27524294)
26. Greisinger AH. Primary care patients' understanding of colorectal cancer screening. Cancer Detect Prev 2006; 30 (1): 2006
27. Messina CR, Lane DS, Grimson R, et al. Colorectal cancer screening attitudes and practices preferences for decision making. Am J Prev Med 2005; 28 (5): 439-446 (Pubitemid 40719045)
28. O'Malley AS, Beaton E, Yabroff KR, et al. Patient and provider barriers to colorectal cancer screening in the primary care safety-net. Prev Med 2004; 39: 56-63 (Pubitemid 38797956)
29. Marshall DA, Johnson FR, Kulin NA, et al. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated- choice survey. Health Econ 2009 Dec; 18 (12): 1420-1439
30. Hawley ST, Volk RJ, Krishnamurthy P, et al. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care 2008; 46 (9 Suppl. 1): S10-6
31. Frew EJ, Wolstenholme JL, Whynes DK, et al. Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats. Health Policy 2004; 68 (3): 289-298
32. Whynes DK, Frew E, Wolstenholme JL, et al. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening. J Health Econ 2003; 22 (4): 555-574 (Pubitemid 36802171)
33. Gyrd-Hansen D, Sogaard J. Analysing public preferences for cancer screening programmes. Health Econ 2001; 10: 617-634 (Pubitemid 32998373)
34. Phillips KA, Van Bebber S, Marshall D, et al. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis 2006; 3 (3): A75 [online]. Available from URL: http://www.cdc.gov/pcd/issues/2006/jul/05- 0208.htm [Accessed 2010 Mar 18]
35. Frew E, Wolstenholme JL, Whynes DK, et al. Willingnessto- pay for colorectal cancer screening. Eur J Cancer 2001; 37 (14): 1746-1751 (Pubitemid 32817048)
36. Howard K, Salkeld G. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health 2009; 12: 354-363
37. Kromm S, Currie G, Heitman S, et al. Preferances for colorectal cancer screening: are primary care physicians and the public on the same page? [abstract]. Gastroenterology 2007; 132 (4 Suppl. 2): A316
38. Hol L, van Dam L, de Bekker-Grob EW, et al. What determines individuals' preferences for colorectal cancer screening tests? A discrete choice experiment. Gastroenterology 2009; 136 (5 Suppl. 1): A766
39. Carson RT, Flores NE, Martin KM, et al. Contingent valuation and revealed preference methodologies: comparing the estimates for quasi-public goods. Land Econ 1996; 72: 80-99
40. Mitchell RC, Carson RT. Using surveys to value public goods: the contingent valuation method. Washington, DC: Resources for the Future, 1989
41. Nunes PALD, Schokkaert E. Identifying the warm glow effect in contingent valuation. J Environ Econ Manage 2003; 45: 231-245 (Pubitemid 36400397)
42. Bridges JFP, Kinter ET, Kidane L, et al. Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007. Patient 2008; 1 (4): 273-282
43. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med 1999; 14: 432-437 (Pubitemid 29344619)
44. Leard LE, Savides TJ, Ganiats TG, et al. Patient preferences for colorectal cancer screening. J Fam Pract 1997; 45 (3): 211-218 (Pubitemid 27391519)
45. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998; 317 (7158): 559-565 (Pubitemid 28395924)
46. Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009; 338: b1846
47. Turner GB, Chin MW, Foster NM, et al. Attitudes of Western Australian general practitioners to colorectal cancer screening [letter]. Med J Aust 2006; 185 (4): 237
48. Ross LE, Richardson LC, Berkowitz Z, et al. The effect of physician-patient discussions on the likelihood of prostatespecific antigen testing. J Natl MedAssoc 2006; 98 (11): 1823-1829 (Pubitemid 44885539)
49. Shokar NK, Carlson CA, Shokar GS, et al. Physician and patient influences on the rate of colorectal cancer screening in a primary care clinic. J Cancer Educ 2006; 21 (2): 84-88
50. Goldsmith G, Chiaro C, Goldsmith G, et al. Colorectal cancer screening: how to help patients comply. J Fam Pract 2008; 57 (7): E2-7
51. Sabatino SA. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives.Am J Prev Med 2008; 35 (1): S67-74
52. Katsumura Y, Yasunaga H, Imamura T, et al. Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: analysis using the analytic hierarchy process. BMC Health Services Research 2008; 8: 106 (Pubitemid 351794091)
53. The Multicentre Australian Colorectal-Neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 2006; 184: 546-550
54. Frew E,Wolstenholme J,WhynesD.Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. J Health Serv Res Policy 2001; 6: 85-91 (Pubitemid 32410451)
55. Wolf RL, Basch CE, Brouse CH, et al. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006; 96: 809-811